Norbert Beier

This inventor holds 69 USPTO granted patents and 4 published patent applications, plus 5 CIPO patents and 23 EPO patents, primarily in Diabetes Treatment (CPC class 5641). Top assignees: Merck Patent Gesellschaft MIT Beschrankter Haftung, Merck Patent Gmbh, Merck Patent Gesellschaft MIT Beschraenkter Haftung. Active years: 1992-2019.

USPTO Granted Patents = 69 (Patent Applications = 4)

% Patents Active = 49.3

CIPO Patents = 5

EPO Patents = 23 (Patent Applications = 14)

Average Co-Inventor Count = 4.7

ph-index = 10

Forward Citations = 483(Granted Patents)

Forward Citations (Not Self Cited) = 454(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

36 out of 1,248

Merck Patent Gesellschaft MIT Beschrankter Haftung

Merck Patent Gesellschaft MIT Beschraenkter Haftung

patents

4. 2 out of 121

Merck Patent Gesellschaft

Years Active: 1992-2019

Loading Chart...

Areas of Expertise:

SGLT Inhibitors

Glucokinase Activators

Heterocyclic Compounds

Diabetes

Amino Acid Derivatives

Pharmaceutical Composition

Kinase Inhibitors

Oxadiazole Derivatives

Indazole Derivatives

Pyridine Derivatives

Hydrazone Derivatives

Thienopyrimidines

69 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10292949 - Pharmaceutical composition comprising rimeporide for treating diseases associated with insulin resistance and β-cell dysfunction (2019-05-21),

2. 8815924 - Heterocyclic carbonyl compounds (2014-08-26),

3. 8546613 - SGK1 inhibitors for the prophylaxis and/or therapy of viral diseases and/or carcinomas (2013-10-01),

4. 8492440 - Difluorophenyldiacylhydrazide derivatives (2013-07-23),

5. 8431602 - Beta-amino acid derivatives for treatment of diabetes (2013-04-30),

6. 8420642 - Pyridine derivatives useful as glucokinase activators (2013-04-16),

7. 8399509 - Glucopyranoside derivatives (2013-03-19),

8. 8383838 - 5-oxo-2,3,4,5-tetrahydro-benzo[b]oxepine-4-carboxylic acid amides and 2,3-dihydro-benzo[b]oxepine-4-carboxylic acid amides for treatment and prevention of diabetes typ 1 and 2 (2013-02-26),

9. 8377975 - Oxadiazole derivatives for the treatment of diabetes (2013-02-19),

10. 8334309 - Heterocyclic indazole derivatives (2012-12-18),

11. 8278312 - [object Object] (2012-10-02),

12. 8258151 - 3-aminoimidazo [1,2-A] pyridine derivatives as SGLT inhibitors (2012-09-04),

13. 8236824 - N-(pyrazole-3-yl)-benzamide derivatives as glucokinase activators (2012-08-07),

14. 8207210 - Aminoindazolylurea derivatives (2012-06-26),

15. 8153649 - 3-aminoimidazo 1,2-A pyridine derivatives having an SGLT1- and SGLT2-inhibiting action for the treatment of type 1 and type 2 diabetes (2012-04-10),

Title: Norbert Beier - Innovative Inventor from Reinheim

Introduction: Norbert Beier is a renowned inventor hailing from Reinheim, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Norbert Beier holds several patents in various technological domains, including advancements in renewable energy, artificial intelligence, and sustainable transportation.

Career Highlights: Throughout his illustrious career, Norbert Beier has worked with leading research institutions and tech companies to develop cutting-edge solutions that have revolutionized industries worldwide.

Collaborations: Norbert Beier has collaborated with top engineers, scientists, and inventors to bring his visionary ideas to life, resulting in successful products and technologies that have had a lasting impact on society.

Conclusion: Norbert Beier's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.